Meta-analysis shows reduced oral microbial Shannon diversity in Crohn's disease versus controls
Oral bacteria shifts could reveal Crohn's disease risk
This meta-analysis reviews data from multiple cohorts involving 1,136 IBD patients and 759 controls. The authors synthesize findings on oral…
A new study links distinct mouth bacteria changes to higher gut inflammation levels in Crohn's disease patients.
Enteral nutrition therapy associated with clinical remission in 60% of Chinese inflammatory bowel disease patients over 6 weeks
Enteral nutrition helps many IBD patients reach remission faster
This retrospective cohort study evaluated enteral nutrition therapy in 750 Chinese patients with Crohn's disease or ulcerative colitis. Appr…
Special liquid food formulas helped 60% of patients reach remission faster while improving nutrition and reducing inflammation in their bodi…
Three Biomarkers Show High Diagnostic Accuracy for Ulcerative Colitis in Cohort Study
Three biomarkers show promise for diagnosing ulcerative colitis
This cohort study evaluated ARHGEF3, S100A8, and RHOU as diagnostic biomarkers for ulcerative colitis. A nomogram achieved AUCs of 0.991 in …
A new study identifies three biomarkers that may help diagnose ulcerative colitis and distinguish it from Crohn's disease.
Network meta-analysis of dietary supplements for ulcerative colitis management
Some dietary supplements may help ulcerative colitis symptoms and quality of life
This network meta-analysis of 24 randomized controlled trials with 1,491 participants synthesized evidence on dietary supplements for ulcera…
A review of 24 trials found certain supplements like probiotics and flaxseed extract may ease ulcerative colitis symptoms and improve qualit…
First Report of Vedolizumab-Associated Recall Urticaria in a Case Report and Literature Review
Why Hives Return to Old Injection Spots
This case report and literature review describes the first documented instance of vedolizumab-associated recall urticaria in a 25-year-old m…
A new case report reveals a rare skin reaction where hives return strictly to past injection sites.
FDA Approves Stelara (ustekinumab) for moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
The FDA approved a drug called Stelara to treat several inflammatory conditions in adults and children.
The FDA approved ustekinumab for adult and pediatric patients 6 years and older with moderate to severe plaque psoriasis and active psoriati…
FDA approved Stelara to treat moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis in adults an…
FDA Approves Stelara (ustekinumab) for moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
The FDA has approved a new drug called Stelara for several inflammatory conditions.
The FDA approved ustekinumab for adult and pediatric patients 6 years and older with moderate to severe plaque psoriasis and active psoriati…
The FDA has approved Stelara to treat moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis in a…
Narrative review discusses M cell manipulation limitations in inflammatory bowel disease models
Can we target gut cells without breaking the whole immune system?
This narrative review addresses challenges in selectively manipulating M cells within traditional animal models and two-dimensional culture …
Scientists are looking for ways to treat Crohn's disease and ulcerative colitis by focusing on specific cells in the gut lining. Current met…
Literature review synthesizes Schisandra chinensis effects on gut microbiota and metabolic pathways across multiple conditions.
This Ancient Berry May Quiet Inflammation From Your Gut to Your Brain
This literature review examines the potential of Schisandra chinensis regarding gut health and metabolic regulation. The authors synthesize …
An ancient berry used for centuries may rebalance gut bacteria to calm inflammation linked to digestive issues, liver disease, diabetes, and…
AI endoscopic score shows better agreement with ulcerative colitis remission than Mayo score in RCT.
AI endoscopic scoring shows better agreement with ulcerative colitis symptoms in trial
This phase 3 RCT in 387 subjects with ulcerative colitis compared an AI endoscopic cumulative disease score (CDS) to the Mayo endoscopic sco…
An AI scoring system matched ulcerative colitis symptoms better than standard endoscopy, helping doctors align what they see with how patien…
Neutrophil SIRL-1/IL-8 Ratio as a Diagnostic Biomarker for Inflammatory Bowel Disease
New Blood Ratio Could Spot IBD Faster
This single-center cohort study measured neutrophil SIRL-1 and serum IL-8 in 90 IBD patients and healthy volunteers. The SIRL-1/IL-8 ratio s…
A new blood ratio measuring two immune signals could help doctors diagnose Crohn's and Ulcerative Colitis faster and more accurately.
Narrative review examines ulcerative colitis and colorectal cancer risk
Review of ulcerative colitis and colorectal cancer links in patients
This narrative review synthesizes evidence on ulcerative colitis and colorectal cancer risk. It discusses factors influencing this associati…
Ulcerative colitis patients face cancer risk driven by inflammation, but better disease control and modern treatments are lowering overall c…